Fakih IVF marks UAE 15th anniversary with free IVF initiative
Fakih IVF is marking 15 years of operating in the UAE with a community programme it calls "15 Years of Family," under which the clinic group will offer 15 complimentary IVF cycles to families who cannot afford fertility treatment. Applications opened in September 2026, and the company says eligibility will be subject to medical and programme criteria that have not yet been published in full.
The initiative coincides with the UAE's formal designation of 2026 as the Year of the Family, a national agenda priority that has prompted a range of corporate and government-backed social programmes across the Emirates.
From one clinic to eight
Fakih IVF opened what it describes as Dubai's first private IVF centre and has since expanded to more than eight fertility clinics across the UAE. Dr Michael Fakih, founder and chairman of the Fakih IVF Fertility Group, said the group's ambition from the outset was to ensure that families in the UAE could access reproductive care locally rather than travelling abroad for treatment.
"Our legacy is not defined by the number of years we have been here or the number of centres we have opened," Dr Fakih said. "It is defined by the thousands of families whose journeys we have been privileged to share."
The release highlights investments in embryology, genetics, precision diagnostics and laboratory infrastructure over the 15-year period, though it does not provide clinical outcome data, cycle volumes, or comparative success rates.
Fertility care in the Gulf region
The UAE's private fertility sector has expanded considerably over the past decade, driven by a combination of population growth, rising awareness of reproductive health, and government investment in healthcare infrastructure. The country has attracted several international fertility networks and specialist clinics, increasing competitive pressure on established local operators such as Fakih IVF.
Across the broader Gulf Cooperation Council market, demand for assisted reproductive technology continues to grow, supported by favourable regulatory frameworks and, in some jurisdictions, partial insurance reimbursement for fertility treatment.